Biotech

All Articles

Former Seagen CEO introduces brand-new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer last year f...

Ironwood makes additional bid for $1B GI medicine with brand-new subgroup information

.On the heels of a period 3 win that failed to excite entrepreneurs, Ironwood Pharmaceuticals is act...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Do not stop Monte Rosa Therapies right now. The Boston-based biotech is actually having a ball afte...

Jade takes exec crew with Chinook veterinarians-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our roundup of significant management hirings, shootings an...

Septerna goes public with upsized offering of $288M

.Celebrating his business's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...

AbbVie brings in Richter wealthier, paying $25M to create discovery deal

.AbbVie has returned to the source of its antipsychotic goliath Vraylar looking for an additional hi...

GenSight enters last weeks of cash money runway as revenue stream squeezes by of scope

.GenSight Biologics is actually full weeks out of lacking loan. Again. The biotech merely has adequa...

AZ licenses thrown out unusual health condition medicine to Monopar Therapeutics

.Monopar Therapeutics is actually recuperating a medication from the dump of AstraZeneca's rare heal...

Arcus' brand-new HIF-2a data in renal cancer hint at possible upper hand over Merck's Welireg, analysts mention

.With brand-new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of profes...

Roche bets as much as $1B to increase Dyno gene therapy distribution deal

.After developing a gene treatment alliance with Dyno Therapeutics in 2020, Roche is back for even m...